What are the side effects of Daridorexant and how to deal with them?

Daridorexant is a new dual orexin receptor antagonist (DORA), mainly used to treat insomnia, especially for patients with difficulty falling asleep and maintaining sleep. It helps patients fall asleep more naturally by inhibiting wake signaling pathways without inhibiting normal nervous system function. However, although the drug has shown good safety in clinical practice, it may still cause a series of side effects. Understanding these possible adverse reactions and mastering the corresponding treatment strategies are of great significance for patients to use DaliRasen safely and effectively.

First of all, the most common side effects of DaliRazen include drowsiness, fatigue, headache, and nausea. These reactions are in most cases mild to moderate and gradually lessen within a few days of taking the drug. For patients with daytime sleepiness, it is recommended to adjust the medication time, preferably 30 minutes before planned sleep, and ensure adequate sleep time (at least 7 hours) to avoid residual sedation effects the next morning. If fatigue or headache significantly affects your quality of life, you can reduce the dosage under the guidance of a doctor, or consider changing to other sleep aids. Coadministration with other CNS depressants should be avoided to reduce the risk of enhanced sedation.

Secondly, some users may experience central nervous system reactions such as decreased attention, memory loss, abnormal behavior, or sleepwalking. Although these conditions are less common in clinical trials, patients with a history of depression, anxiety, or psychotic disorders should be particularly aware of the risk that medications may worsen psychiatric symptoms. If the patient has abnormal speech and behavior, abnormal dreams, or confusion, it is recommended to stop taking the drug immediately and seek medical evaluation. Clinically, it is sometimes found that the symptoms of patients with nocturnal behavioral disorder worsen after taking DORA drugs. In this case, the use of these drugs should be avoided.

In addition, DaliRasen may cause symptoms such as muscle weakness, unsteady gait, or dizziness, especially in the elderly. These side effects may increase the risk of falls, especially when getting up at night. In order to reduce this risk, it is recommended that patients avoid frequent activities at night while taking the medication, and if necessary, set up night lights and anti-slip facilities in the room to improve safety. When elderly patients start using DaliRasen, they should start with a lower dose and gradually evaluate its effects on the body.

DaliRasen should also be used with caution in special groups of people. For example, patients with hepatic impairment may experience drug accumulation due to slowed drug metabolism, thereby increasing the risk of side effects. This drug should be avoided in people with moderate to severe liver dysfunction. The safety of use by pregnant and breastfeeding women has not been established and its use is generally not recommended. For patients taking other drugs, such as CYP3A4 strong inhibitors (such as clarithromycin, itraconazole, etc.), the blood concentration of daliramson may increase, thereby enhancing side effects. Concurrent use or dose adjustment should be avoided.

In general, DaliRasen acts as a targeted sleep regulator-New drugs for awakening rhythms have relatively few side effects, and most of them can be alleviated through rational use of drugs and lifestyle adjustments. During the period of using this drug, patients should regularly monitor drug reactions and communicate with their doctors about discomfort in a timely manner to achieve safe and effective treatment goals. Proper management of side effects not only improves patient compliance but also enhances the overall treatment experience.

Reference materials：https://www.quviviq.com/